Comparison of the efficacy of intralesional bleomycin plus intralesional triamcinolone in the treatment of keloids.
Phase 2
Recruiting
- Conditions
- keloid.
- Registration Number
- IRCT20221209056760N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients between the ages of 18 and 60
Refractory keloid: Relapse or not cured despite six sessions of intra-triamcyonolone acetonide injection.
Exclusion Criteria
Dissatisfaction with the study
sensitivity to bleomycin
pregnant or breast feeding
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of the efficacy of keloid treatment by intralesional injection of bleomycin in combination with intralesion injection of triamcinolone.(pigmentation, vascularity, pliability and thickness). Timepoint: The Beginning of the study and then every 4 weeks and up to 6 sessions (end of study). Method of measurement: The VSS (Vancouver Scar Scale) scale and examining the patient.
- Secondary Outcome Measures
Name Time Method Relapse rate. Timepoint: Beginning of the study and then every 4 weeks and up to 6 sessions (end of study). Method of measurement: The VSS (Vancouver Scar Scale) scale.;Complication of treatment. Timepoint: Beginning of the study and then every 4 weeks and up to 6 sessions (end of study). Method of measurement: observation and asking for the patients.